INTELLIGENT BIO SOLUTIONS INC. (INBS) Operating Margin
- Operating margin · 12 months: Value -299.11%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -299.11% | Operating income / revenue. Period ending 2026-06-30. $-12.61M ÷ $4.22M × 100 ≈ -299.11% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -12.61M USD | Operating Income (Loss) |
| Revenue | 4.22M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 10.50M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-12.61M | $4.22M | (m) | (m) | $10.50M | -299.11% |
| 2026-03-31 | $-11.71M | $3.91M | (m) | (m) | (m) | -299.27% |
| 2025-12-31 | $-11.29M | $3.58M | (m) | (m) | (m) | -315.25% |
| 2025-09-30 | $-10.92M | $3.29M | (m) | (m) | (m) | -331.68% |
| 2025-06-30 | $-10.64M | $3.05M | (m) | (m) | (m) | -348.71% |
| 2025-03-31 | $-10.35M | $2.94M | (m) | (m) | (m) | -352.62% |
| 2024-12-31 | $-10.76M | $3.03M | (m) | (m) | (m) | -354.79% |
| 2024-09-30 | $-10.48M | $3.19M | (m) | (m) | (m) | -328.80% |
| 2024-06-30 | $-10.28M | $3.11M | (m) | (m) | (m) | -330.46% |
| 2024-03-31 | $-10.17M | $2.83M | (m) | (m) | (m) | -359.87% |
| 2023-12-31 | $-13.76M | $2.46M | (m) | (m) | (m) | -559.42% |
| 2023-09-30 | $-13.90M | $1.74M | (m) | (m) | (m) | -798.28% |
| 2023-06-30 | $-12.60M | $1.26M | (m) | (m) | (m) | -1002.11% |
| 2023-03-31 | $-11.98M | $880.59K | (m) | (m) | (m) | -1360.54% |
| 2022-12-31 | $-6.78M | $616.03K | (m) | (m) | (m) | -1100.63% |
| 2022-09-30 | $-8.12M | $748.47K | (m) | (m) | (m) | -1084.34% |
| 2022-06-30 | $-8.34M | $437.15K | (m) | (m) | (m) | -1907.11% |
| 2022-03-31 | $-7.10M | $1.98M | (m) | (m) | (m) | -359.02% |
| 2021-12-31 | $-8.90M | $1.82M | (m) | (m) | (m) | -489.01% |
| 2021-09-30 | $-6.35M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $-5.57M | $1.98M | (m) | (m) | (m) | -281.42% |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $-2.86M | $188.74K | (m) | (m) | (m) | -1513.69% |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |